Safe Orthopaedics SA (ALSAF) - Net Assets
Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) has net assets worth €-10.68 Million EUR (≈ $-12.49 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€11.81 Million ≈ $13.81 Million USD) and total liabilities (€22.49 Million ≈ $26.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Safe Orthopaedics SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-10.68 Million |
| % of Total Assets | -90.43% |
| Annual Growth Rate | N/A |
| 5-Year Change | -2783.42% |
| 10-Year Change | -3010.08% |
| Growth Volatility | 223.11 |
Safe Orthopaedics SA - Net Assets Trend (2012–2025)
This chart illustrates how Safe Orthopaedics SA's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Safe Orthopaedics SA market cap and net worth.
Annual Net Assets for Safe Orthopaedics SA (2012–2025)
The table below shows the annual net assets of Safe Orthopaedics SA from 2012 to 2025. Also explore net asset momentum of Safe Orthopaedics SA to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €-10.68 Million ≈ $-12.49 Million |
-26.81% |
| 2024-12-31 | €-8.42 Million ≈ $-9.85 Million |
+95.84% |
| 2023-12-31 | €-202.35 Million ≈ $-236.57 Million |
-15721.27% |
| 2022-12-31 | €-1.28 Million ≈ $-1.50 Million |
-421.36% |
| 2021-12-31 | €398.00K ≈ $465.30K |
+67.93% |
| 2020-12-31 | €237.00K ≈ $277.08K |
+105.54% |
| 2019-12-31 | €-4.28 Million ≈ $-5.00 Million |
-458.84% |
| 2018-12-31 | €1.19 Million ≈ $1.39 Million |
+12.76% |
| 2017-12-31 | €1.06 Million ≈ $1.24 Million |
+188.28% |
| 2016-12-31 | €367.00K ≈ $429.06K |
-92.79% |
| 2015-12-31 | €5.09 Million ≈ $5.95 Million |
+106.82% |
| 2014-12-31 | €2.46 Million ≈ $2.88 Million |
+1369.07% |
| 2013-12-31 | €-194.00K ≈ $-226.81K |
-116.61% |
| 2012-12-31 | €1.17 Million ≈ $1.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Safe Orthopaedics SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 132300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €42.00K | % |
| Total Equity | €-10.68 Million | 100.00% |
Safe Orthopaedics SA Competitors by Market Cap
The table below lists competitors of Safe Orthopaedics SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arcontech Group Plc
LSE:ARC
|
$127.73K |
|
Fulcrum Metals PLC
LSE:FMET
|
$129.05K |
|
Angus Energy PLC
LSE:ANGS
|
$129.12K |
|
Velocity Composites plc
LSE:VEL
|
$129.71K |
|
The Investment Company plc
LSE:INV
|
$126.15K |
|
Newmark Security plc
LSE:NWT
|
$124.42K |
|
Sumo Resources PLC
PA:MLSUM
|
$124.00K |
|
IMC Exploration Group Public Limited Company
LSE:IMC
|
$123.48K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Safe Orthopaedics SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -8,422,000 to -10,679,000, a change of -2,257,000.
- Net loss of 4,099,999 reduced equity.
- New share issuances of 1,020,000 increased equity.
- Other factors increased equity by 822,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-4.10 Million | -38.39% |
| Share Issuances | €1.02 Million | +9.55% |
| Other Changes | €823.00K | +7.71% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Safe Orthopaedics SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €0.00 | €0.64 | x |
| 2013-12-31 | €0.00 | €0.64 | x |
| 2014-12-31 | €0.00 | €0.64 | x |
| 2015-12-31 | €0.00 | €0.64 | x |
| 2016-12-31 | €0.00 | €0.64 | x |
| 2017-12-31 | €0.00 | €0.64 | x |
| 2018-12-31 | €0.00 | €0.64 | x |
| 2019-12-31 | €0.00 | €0.64 | x |
| 2020-12-31 | €5925000.00 | €0.64 | x |
| 2021-12-31 | €3255.62 | €0.64 | x |
| 2022-12-31 | €-10462.17 | €0.64 | x |
| 2023-12-31 | €-2312892.90 | €0.64 | x |
| 2024-12-31 | €-1090.93 | €0.64 | x |
| 2025-12-31 | €-59.00 | €0.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Safe Orthopaedics SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -75.93%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-610.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -286.90% | -1027.91% | 0.09x | 3.00x | €-3.47 Million |
| 2013 | 0.00% | -330.20% | 0.23x | 0.00x | €-3.17 Million |
| 2014 | -200.49% | -240428.64% | 0.00x | 2.16x | €-5.18 Million |
| 2015 | -128.95% | -262850.28% | 0.00x | 2.05x | €-7.08 Million |
| 2016 | -1636.24% | -253911.21% | 0.00x | 21.81x | €-6.04 Million |
| 2017 | -622.04% | -211414.79% | 0.00x | 7.62x | €-6.68 Million |
| 2018 | -485.76% | -167098.82% | 0.00x | 7.18x | €-5.92 Million |
| 2019 | 0.00% | -169.61% | 0.83x | 0.00x | €-7.54 Million |
| 2020 | -3504.64% | -227.06% | 0.25x | 60.54x | €-8.33 Million |
| 2021 | -1685.68% | -147.32% | 0.31x | 37.39x | €-6.75 Million |
| 2022 | 0.00% | -118.84% | 0.35x | 0.00x | €-6.84 Million |
| 2023 | 0.00% | -3536.04% | 0.07x | 0.00x | €-185.21 Million |
| 2024 | 0.00% | -38272.64% | 0.46x | 0.00x | €-1.93 Billion |
| 2025 | 0.00% | -75.93% | 0.46x | 0.00x | €-3.03 Million |
Industry Comparison
This section compares Safe Orthopaedics SA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,470,665,133
- Average return on equity (ROE) among peers: -8.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Safe Orthopaedics SA (ALSAF) | €-10.68 Million | -286.90% | N/A | $127.51K |
| Crossject (ALCJ) | $-2.15 Million | 0.00% | 0.00x | $81.55 Million |
| I.Ceram SA (ALICR) | $2.61 Million | -58.47% | 1.19x | $155.73K |
| Spineway (ALSPW) | $20.88 Million | -7.58% | 0.22x | $4.75 Million |
| Amplitude Surgical SAS (AMPLI) | $52.57 Million | -8.35% | 3.94x | $299.85 Million |
| Sartorius Stedim Biotech SA (DIM) | $4.13 Billion | 6.44% | 0.94x | $17.54 Billion |
| EssilorLuxottica S. A. (EL) | $6.09 Billion | 12.43% | 0.97x | $78.17 Billion |
| Bonyf NV (MLBON) | $2.64 Million | -1.38% | 0.26x | $1.46 Million |
About Safe Orthopaedics SA
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more